Pharma Markets

Global Covid-19 Clinical Trial Pipeline Highlights

By Fore Pharma | Published Date: May 24, 2020 | On-Demand Data

The latest research from Fore Pharma, Global Covid-19 Clinical Trial Pipeline Highlights – 2020, provides most up-to-date information on key pipeline products in the global Covid-19 market. It covers emerging therapies for Covid-19 in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this research helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Research Scope:

– Products by Clinical Trial Stages: Covid-19 pipeline products by clinical trial stages including both early and late stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
– Drug Mechanism Classes: Covid-19 pipeline products by their dominant mechanism of action / drug class. This helps executives categorize products based on their drug class.
– Company: Covid-19 pipeline products by developing company.
– Short-term Launch Highlights: Find out which Covid-19 pipeline products will be launched in the US and Ex-US till 2025.

Summary of Contents:

– Covid-19 phase 3 clinical trial pipeline products
– Covid-19 phase 2 clinical trial pipeline products
– Covid-19 phase 1 clinical trial pipeline products
– Covid-19 preclinical research pipeline products
– Covid-19 discovery stage pipeline products
– Covid-19 pipeline products short-term launch highlights

Table of Contents


1. Covid-19 Pipeline by Stages
2. Covid-19 Phase 3 Clinical Trial Insights
3. Covid-19 Phase 2 Clinical Trial Insights
4. Covid-19 Phase 1 Clinical Trial Insights
5. Covid-19 Preclinical Research Insights
6. Covid-19 Discovery Stage Insights
7. Appendix
8. Research Methodology

List of Tables


Table 1: Covid-19 Phase 3 Clinical Trials, 2020
Table 2: Covid-19 Phase 2 Clinical Trials, 2020
Table 3: Covid-19 Phase 1 Clinical Trials, 2020
Table 4: Covid-19 Preclinical Research, 2020
Table 5: Covid-19 Discovery Stage, 2020

List of Figures


Figure 1: Covid-19 Pipeline Molecules by Clinical Trials Stage, 2020
Figure 2: Covid-19 Phase 3 Clinical Trial Highlights, 2020
Figure 3: Covid-19 Phase 2 Clinical Trial Highlights, 2020
Figure 4: Covid-19 Phase 1 Clinical Trial Highlights, 2020
Figure 5: Covid-19 Preclinical Research Highlights, 2020
Figure 6: Covid-19 Discovery Stage Highlights, 2020

Format


Default format is PDF.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies